Spinout Active LTD

Company profile

Myconeos Limited

Myconeos

Myconeos Is a specialist fungal biotechnology research company focused on solutions for the food industry.

CRN
11439215
Founded
2018
Age
8

Overview

Browse spinouts
Legal name
MYCONEOS LIMITED
Region
London
Registered address
C/O FORVIS MAZARS LLP, 30 OLD BAILEY
OLD BAILEY
LONDON
ENGLAND
EC4M 7AU
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
9

Company events

Reference milestones and recent Companies House filing stream events.

6 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

09 Apr
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

26 Mar
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

10 Oct
2024

Accounts With Accounts Type Micro Entity

Accounts Analysed

AA | Transaction MzQzOTA2NTMzMmFkaXF6a2N4

Published 10 Oct 2024 02:41

28 Jun
2018

Incorporated

Inception

Company registered at Companies House

Spinout profile

4 entries

Company description

Myconeos breeds new strains of fungi for a wide range of applications including food, bio-remediation, bio-fermentation and production of enzymes and colours.

The company Myconeos (https://myconeos.com/) was formed as a spin-out from work arising from the BBSRC follow-on-fund awards together with a BBSRC Agri-Food Seeding Catalyst Award. The previous research led to the identification of a series of novel fungal moulds that can be used for the production of novel blue cheeses with improved flavour and colour, which were deemed very attractive in cheese taste trials. Myconeos has the remit to produce, market and further develop the moulds using the technology developed under the previous BBSRC research.

Project impact

Myconeos has identified a commercial distributor, JKM Foods (http://www.jkm-foods.com/), for the novel strains who is an existing major UK supplier. Talks are ongoing with the DTI to establish international distributors. The company has established a production facility at Biocity, Nottingham and has gained HACCP food safety approval in Spring 2022. Commercial strain production and sales have now started as of March 2022. The company has also gained a major £200K Innovate UK grant from 2021-2022. The research work and start-up company were featured on the UKRI website and Youtube as a promotional example: https://www.youtube.com/shorts/yqi9XaaXC3U

Myconeos
2018
Myconeos
2018
MYCONEOS LIMITED
2018

Public funding

3 awards
First funded
2021
Funded years
2021, 2022, 2023
Age at first award
3 years

Projects

2023 Collaborative R&D Lead participant

Development of novel Penicillium strains optimised for mould-ripened plant-based cheese manufacturing

1 Jul 2023 to 31 Dec 2024

Awarded
£282,568
Total cost £403,668

_Penicillium_ fungi are used in mould-ripened dairy cheese production. Frequently used strains include _P. roqueforti_ and _P. camemberti_. These are typically commercial strains purchased from a select few dedicated strain manufacturers that service the global market or are historical strains that have been cultured by the dairy or cheesemakers themselve...

2022 Collaborative R&D Lead participant

Feasibility of developing and exporting novel fungal strains for the mould ripened cheese market in Italy

1 Jan 2022 to 31 Mar 2022

Awarded
£20,884
Total cost £29,835

Myconeos has developed ground breaking technology to naturally breed new fungal strains. We have applied the technology to breed the first new penicillium roqueforti strains in the market for blue cheese application in forty years. These new strains have been selected through evaluation in UK style blue cheeses and consumer work in the UK. The four new UK...

2021 Collaborative R&D Lead participant

Development of novel Penicillium camemberti strains for optimised white rind cheese production

1 Jul 2021 to 31 Dec 2022

Awarded
£199,799
Total cost £285,427

Few strains of the fungus _Penicillium camemberti_ are available for commercial mould-ripened cheese production, despite the fact that there are known manufacturing/quality issues with those available. There is an unmet need for higher-quality _P. camemberti_ production strains, exhibiting improved and novel phenotypic traits for commercial cheese making ...

Product types

Collaborative R&D